1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infusion Services Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Ambulatory Infusion Service
1.2.3 Home-based Infusion Service
1.3 Market by Application
1.3.1 Global Infusion Services Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Chemotherapy/Oncology
1.3.3 Inotropic Therapy/Cardiac Care
1.3.4 Parenteral Nutrition
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Infusion Services Market Perspective (2017-2028)
2.2 Infusion Services Growth Trends by Region
2.2.1 Infusion Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Infusion Services Historic Market Size by Region (2017-2022)
2.2.3 Infusion Services Forecasted Market Size by Region (2023-2028)
2.3 Infusion Services Market Dynamics
2.3.1 Infusion Services Industry Trends
2.3.2 Infusion Services Market Drivers
2.3.3 Infusion Services Market Challenges
2.3.4 Infusion Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infusion Services Players by Revenue
3.1.1 Global Top Infusion Services Players by Revenue (2017-2022)
3.1.2 Global Infusion Services Revenue Market Share by Players (2017-2022)
3.2 Global Infusion Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infusion Services Revenue
3.4 Global Infusion Services Market Concentration Ratio
3.4.1 Global Infusion Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infusion Services Revenue in 2021
3.5 Infusion Services Key Players Head office and Area Served
3.6 Key Players Infusion Services Product Solution and Service
3.7 Date of Enter into Infusion Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infusion Services Breakdown Data by Type
4.1 Global Infusion Services Historic Market Size by Type (2017-2022)
4.2 Global Infusion Services Forecasted Market Size by Type (2023-2028)
5 Infusion Services Breakdown Data by Application
5.1 Global Infusion Services Historic Market Size by Application (2017-2022)
5.2 Global Infusion Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Infusion Services Market Size (2017-2028)
6.2 North America Infusion Services Market Size by Country (2017-2022)
6.3 North America Infusion Services Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Infusion Services Market Size (2017-2028)
7.2 Europe Infusion Services Market Size by Country (2017-2022)
7.3 Europe Infusion Services Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infusion Services Market Size (2017-2028)
8.2 Asia-Pacific Infusion Services Market Size by Country (2017-2022)
8.3 Asia-Pacific Infusion Services Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Infusion Services Market Size (2017-2028)
9.2 Latin America Infusion Services Market Size by Country (2017-2022)
9.3 Latin America Infusion Services Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infusion Services Market Size (2017-2028)
10.2 Middle East & Africa Infusion Services Market Size by Country (2017-2022)
10.3 Middle East & Africa Infusion Services Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 CVS Health
11.1.1 CVS Health Company Detail
11.1.2 CVS Health Business Overview
11.1.3 CVS Health Infusion Services Introduction
11.1.4 CVS Health Revenue in Infusion Services Business (2017-2022)
11.1.5 CVS Health Recent Development
11.2 ContinuumRx
11.2.1 ContinuumRx Company Detail
11.2.2 ContinuumRx Business Overview
11.2.3 ContinuumRx Infusion Services Introduction
11.2.4 ContinuumRx Revenue in Infusion Services Business (2017-2022)
11.2.5 ContinuumRx Recent Development
11.3 Palmetto
11.3.1 Palmetto Company Detail
11.3.2 Palmetto Business Overview
11.3.3 Palmetto Infusion Services Introduction
11.3.4 Palmetto Revenue in Infusion Services Business (2017-2022)
11.3.5 Palmetto Recent Development
11.4 ARJ
11.4.1 ARJ Company Detail
11.4.2 ARJ Business Overview
11.4.3 ARJ Infusion Services Introduction
11.4.4 ARJ Revenue in Infusion Services Business (2017-2022)
11.4.5 ARJ Recent Development
11.5 Elevation
11.5.1 Elevation Company Detail
11.5.2 Elevation Business Overview
11.5.3 Elevation Infusion Services Introduction
11.5.4 Elevation Revenue in Infusion Services Business (2017-2022)
11.5.5 Elevation Recent Development
11.6 Optum
11.6.1 Optum Company Detail
11.6.2 Optum Business Overview
11.6.3 Optum Infusion Services Introduction
11.6.4 Optum Revenue in Infusion Services Business (2017-2022)
11.6.5 Optum Recent Development
11.7 Option Care Health
11.7.1 Option Care Health Company Detail
11.7.2 Option Care Health Business Overview
11.7.3 Option Care Health Infusion Services Introduction
11.7.4 Option Care Health Revenue in Infusion Services Business (2017-2022)
11.7.5 Option Care Health Recent Development
11.8 Vital Care
11.8.1 Vital Care Company Detail
11.8.2 Vital Care Business Overview
11.8.3 Vital Care Infusion Services Introduction
11.8.4 Vital Care Revenue in Infusion Services Business (2017-2022)
11.8.5 Vital Care Recent Development
11.9 Aultman
11.9.1 Aultman Company Detail
11.9.2 Aultman Business Overview
11.9.3 Aultman Infusion Services Introduction
11.9.4 Aultman Revenue in Infusion Services Business (2017-2022)
11.9.5 Aultman Recent Development
11.10 OSF HealthCare
11.10.1 OSF HealthCare Company Detail
11.10.2 OSF HealthCare Business Overview
11.10.3 OSF HealthCare Infusion Services Introduction
11.10.4 OSF HealthCare Revenue in Infusion Services Business (2017-2022)
11.10.5 OSF HealthCare Recent Development
11.11 WellSpan Health
11.11.1 WellSpan Health Company Detail
11.11.2 WellSpan Health Business Overview
11.11.3 WellSpan Health Infusion Services Introduction
11.11.4 WellSpan Health Revenue in Infusion Services Business (2017-2022)
11.11.5 WellSpan Health Recent Development
11.12 Owens Healthcare
11.12.1 Owens Healthcare Company Detail
11.12.2 Owens Healthcare Business Overview
11.12.3 Owens Healthcare Infusion Services Introduction
11.12.4 Owens Healthcare Revenue in Infusion Services Business (2017-2022)
11.12.5 Owens Healthcare Recent Development
11.13 Trios Health
11.13.1 Trios Health Company Detail
11.13.2 Trios Health Business Overview
11.13.3 Trios Health Infusion Services Introduction
11.13.4 Trios Health Revenue in Infusion Services Business (2017-2022)
11.13.5 Trios Health Recent Development
11.14 Legacy Health
11.14.1 Legacy Health Company Detail
11.14.2 Legacy Health Business Overview
11.14.3 Legacy Health Infusion Services Introduction
11.14.4 Legacy Health Revenue in Infusion Services Business (2017-2022)
11.14.5 Legacy Health Recent Development
11.15 PruittHealth
11.15.1 PruittHealth Company Detail
11.15.2 PruittHealth Business Overview
11.15.3 PruittHealth Infusion Services Introduction
11.15.4 PruittHealth Revenue in Infusion Services Business (2017-2022)
11.15.5 PruittHealth Recent Development
11.16 Amerita
11.16.1 Amerita Company Detail
11.16.2 Amerita Business Overview
11.16.3 Amerita Infusion Services Introduction
11.16.4 Amerita Revenue in Infusion Services Business (2017-2022)
11.16.5 Amerita Recent Development
11.17 Johns Hopkins
11.17.1 Johns Hopkins Company Detail
11.17.2 Johns Hopkins Business Overview
11.17.3 Johns Hopkins Infusion Services Introduction
11.17.4 Johns Hopkins Revenue in Infusion Services Business (2017-2022)
11.17.5 Johns Hopkins Recent Development
11.18 MultiCare
11.18.1 MultiCare Company Detail
11.18.2 MultiCare Business Overview
11.18.3 MultiCare Infusion Services Introduction
11.18.4 MultiCare Revenue in Infusion Services Business (2017-2022)
11.18.5 MultiCare Recent Development
11.19 North Oaks Health System
11.19.1 North Oaks Health System Company Detail
11.19.2 North Oaks Health System Business Overview
11.19.3 North Oaks Health System Infusion Services Introduction
11.19.4 North Oaks Health System Revenue in Infusion Services Business (2017-2022)
11.19.5 North Oaks Health System Recent Development
11.20 Gundersen Health System
11.20.1 Gundersen Health System Company Detail
11.20.2 Gundersen Health System Business Overview
11.20.3 Gundersen Health System Infusion Services Introduction
11.20.4 Gundersen Health System Revenue in Infusion Services Business (2017-2022)
11.20.5 Gundersen Health System Recent Development
11.21 Binson's Pharmacy
11.21.1 Binson's Pharmacy Company Detail
11.21.2 Binson's Pharmacy Business Overview
11.21.3 Binson's Pharmacy Infusion Services Introduction
11.21.4 Binson's Pharmacy Revenue in Infusion Services Business (2017-2022)
11.21.5 Binson's Pharmacy Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
